About this trial
The goal of this randomized controlled trial is to find out whether the brief, 10-session Developmentally Oriented Cognitive Therapy for Social Anxiety Disorder (DOCT-SAD) is more effective than standard counseling (SC) to treat Social Anxiety Disorder (SAD) among 12 to 17-year-old adolescents with SAD.
Potential participants for the study are identified from school health and well-being services (SHWS). The DOCT-SAD is delivered by method-trained school psychologists working in the SHWS. SC will be provided by non-method-trained SHWS professionals (i.e. school nurses, social workers or school psychologists) according to their routine counselling practice.
The main research questions of the study are:
1. Is DOCT-SAD more effective than SC for alleviating symptoms of social anxiety? 2. Is DOCT-SAD more effective than SC to produce diagnostic remission from primary SAD and alleviating symptom severity associated with SAD? 3. Is DOCT-SAD more effective than SC for alleviating co-occurring depressive symptoms, interference in daily functioning due to worry or fears, and for increasing general well-being, positive mental health, and for improving the quality of life among adolescents with SAD?
Researchers will compare DOCT-SAD with SC to see if DOCT-SAD is effective in the treatment of SAD in adolescents.
Participants will:
* be treated either with DOCT-SAD or SC for 10 weeks. * be followed up and assessed clinically at six-month and twelve-month follow-up points.
Eligibility criteria
Qualifiers
age 13-17 years
diagnosis of DSM-5 SAD (Social Anxiety Disorder)
SAD is the primary mental health disorder
motivation of the adolescent and parent to attend DOCT-SAD / SC as described in the study protocol
Disqualifiers
intellectual deficit
presence of primary autism spectrum disorder
marked psychotic symptoms or psyhotic disorder
severe eating disorder, depression or primary other anxiety disorder requiring acute treatment which need to be prioritized above treatment of social anxiety
Trial design
Treatments tested in this trial
- DOCT-SAD
- SC
Treatment groups
Sponsors and collaborators
Klaus Ranta
Lead sponsor
Tampere University
Sponsor institution
University of Helsinki
Collaborator
Finnish Institute for Health and Welfare
Collaborator
University of Eastern Finland
Collaborator